Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,967 | 8,258 | 7,404 | 5,346 | 5,699 |
| Receivables | N/A | N/A | N/A | N/A | 4 |
| Other current assets | 0 | 0 | 0 | 0 | 11 |
| TOTAL | $7,047 | $8,382 | $7,535 | $5,485 | $5,724 |
| Non-Current Assets | |||||
| PPE Net | 175 | 155 | 137 | 87 | 82 |
| Intangibles | 127 | 111 | 111 | 24 | 23 |
| Other Non-Current Assets | 49 | 49 | 43 | 43 | 36 |
| TOTAL | $352 | $316 | $292 | $154 | $141 |
| Total Assets | $7,399 | $8,697 | $7,826 | $5,638 | $5,865 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 936 | 494 | 1,017 | 858 | 542 |
| TOTAL | $936 | $494 | $1,017 | $866 | $547 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 15 | 19 |
| TOTAL | $N/A | $N/A | $N/A | $15 | $19 |
| Total Liabilities | $936 | $494 | $1,017 | $880 | $566 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,151 | 32,076 | 32,076 | 30,038 | 29,184 |
| Common Shares | 322 | 321 | 314 | 300 | 292 |
| Retained earnings | -50,888 | -47,931 | -45,656 | -42,762 | -41,341 |
| TOTAL | $6,463 | $8,203 | $6,809 | $4,758 | $5,299 |
| Total Liabilities And Equity | $7,399 | $8,697 | $7,826 | $5,638 | $5,865 |